Apvo stock forecast

SEATTLE, May 09, 2019 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology, autoimmune and hematology therapeutics, today provided a business review and reported its financial results for the first quarter ended March 31, 2019. Do Not Miss This Chance On Aptevo Therapeutics Inc. (APVO ... Mar 17, 2020 · Aptevo Therapeutics Inc. (NASDAQ:APVO) increased by 19.11%, which means its valuation on the stock-market now stands at $19.34M. Its share price closed at $0.28, having traded in a uptrend. Similarly, significant improvements in trading activity saw average volumes at the ready counter drop to 1,797,058 shares.

©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed  APVO | Complete Aptevo Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Find the latest Aptevo Therapeutics Inc. (APVO) stock quote, history, news and other vital information to help you with your stock trading and investing. Aptevo Therapeutics Stock Price Forecast, APVO stock price prediction. Price target in 14 days: 7.929 USD. The best long-term & short-term Aptevo Therapeutics  APVO investment & stock information. Get the latest Aptevo Therapeutics Inc. APVO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Get today's Aptevo Therapeutics Inc stock price and latest APVO news as well as Aptevo Therapeutics real-time stock quotes, technical analysis, full financials 

Aptevo Therapeutics Inc. Common Stock (APVO) Real-Time ...

Mar 13, 2019 · The current consensus rating on Aptevo Therapeutics Inc (NASDAQ:APVO) is Buy with a consensus target price of $10.00 per share, a potential 1,036.36% upside. Should You Buy Aptevo Therapeutics Inc. (APVO)’s Stock ... Mar 16, 2020 · APVO shares had a relatively better volume day versus average trading capacity of 963.85 thousand shares, but with a 41.62 million float and a -37.7% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for APVO stock indicates that the average analyst price target is … ADMP Adamis Pharmaceuticals Corporation — Stock Price and ... Apr 03, 2020 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Aptevo Aptevo Therapeutics is not the usual biotech company. Our proprietary ADAPTIR™ (modular protein technology) platform, the most innovative minds in the field, and a culture of employee ownership empower us to advance the science of what’s next in oncology and hematology.

APVO - Aptevo Therapeutics Inc Stock quote - CNNMoney.com

Find the latest Aptevo Therapeutics Inc. (APVO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get today's Aptevo Therapeutics Inc stock price and latest APVO news as well as Aptevo Therapeutics real-time stock quotes, technical analysis, full financials 

APVO Aptevo Therapeutics Inc. Stock Quote

APVO Stock Quote - Aptevo Therapeutics Inc. Common Stock ...

Mar 16, 2020 · APVO shares had a relatively better volume day versus average trading capacity of 963.85 thousand shares, but with a 41.62 million float and a -37.7% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for APVO stock indicates that the average analyst price target is … ADMP Adamis Pharmaceuticals Corporation — Stock Price and ...

APVO Stock Analysis: Price, Forecast, and News APVO Stock Analysis Overview . What this means: InvestorsObserver gives Aptevo Therapeutics Inc (APVO) an overall rank of 50, which is below average. Aptevo Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Aptevo Therapeutics Inc - APVO - Stock forecast - 3 months ... Jul 29, 2019 · APVO stock forecast Our latest prediction for Aptevo Therapeutics, Inc.'s stock price was made on the July 29, 2019 when the stock price was at 0.84$. In the short term (2weeks), APVO's stock price should outperform the market by 6.02%. During that period the price should oscillate between -8.01% and +15.94%.